JP2017008002A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017008002A5 JP2017008002A5 JP2015127862A JP2015127862A JP2017008002A5 JP 2017008002 A5 JP2017008002 A5 JP 2017008002A5 JP 2015127862 A JP2015127862 A JP 2015127862A JP 2015127862 A JP2015127862 A JP 2015127862A JP 2017008002 A5 JP2017008002 A5 JP 2017008002A5
- Authority
- JP
- Japan
- Prior art keywords
- vitamin
- agent according
- fatigue agent
- ornithine
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000002929 anti-fatigue Effects 0.000 claims 5
- 239000003795 chemical substances by application Substances 0.000 claims 5
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims 3
- 229960003104 Ornithine Drugs 0.000 claims 3
- 239000004480 active ingredient Substances 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 239000011780 sodium chloride Substances 0.000 claims 3
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 2
- 235000001014 amino acid Nutrition 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 2
- PVXPPJIGRGXGCY-IPFGBZKGSA-N 6-O-α-D-glucopyranosyl-β-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@](O)(CO)O1 PVXPPJIGRGXGCY-IPFGBZKGSA-N 0.000 claims 1
- MYYIAHXIVFADCU-QMMMGPOBSA-N Anserine Chemical compound CN1C=NC=C1C[C@H](NC(=O)CC[NH3+])C([O-])=O MYYIAHXIVFADCU-QMMMGPOBSA-N 0.000 claims 1
- 108010085443 Anserine Proteins 0.000 claims 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N Aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims 1
- 108010011485 Aspartame Proteins 0.000 claims 1
- 229960003438 Aspartame Drugs 0.000 claims 1
- 241000196324 Embryophyta Species 0.000 claims 1
- 229960000304 Folic Acid Drugs 0.000 claims 1
- 229960002989 Glutamic Acid Drugs 0.000 claims 1
- 239000004471 Glycine Substances 0.000 claims 1
- 229960000310 ISOLEUCINE Drugs 0.000 claims 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 1
- 239000004472 Lysine Substances 0.000 claims 1
- 229940053207 Niacin Drugs 0.000 claims 1
- 240000007594 Oryza sativa Species 0.000 claims 1
- 235000007164 Oryza sativa Nutrition 0.000 claims 1
- 229960005190 Phenylalanine Drugs 0.000 claims 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims 1
- 235000011613 Pinus brutia Nutrition 0.000 claims 1
- 241000018646 Pinus brutia Species 0.000 claims 1
- 240000001203 Potentilla anserina Species 0.000 claims 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N Trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims 1
- 229940029983 VITAMINS Drugs 0.000 claims 1
- 229930003451 Vitamin B1 Natural products 0.000 claims 1
- 229930003779 Vitamin B12 Natural products 0.000 claims 1
- 229940011671 Vitamin B6 Drugs 0.000 claims 1
- 229930003629 Vitamin B6 Natural products 0.000 claims 1
- 229940046009 Vitamin E Drugs 0.000 claims 1
- 229930003427 Vitamin E Natural products 0.000 claims 1
- 229940021016 Vitamin IV solution additives Drugs 0.000 claims 1
- 229940046010 Vitamin K Drugs 0.000 claims 1
- 229930003448 Vitamin K Natural products 0.000 claims 1
- 229940019697 Vitamin K containing hemostatics Drugs 0.000 claims 1
- 229940046282 Zinc Drugs 0.000 claims 1
- 229940091251 Zinc Supplements Drugs 0.000 claims 1
- 239000000605 aspartame Substances 0.000 claims 1
- 235000010357 aspartame Nutrition 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 125000003346 cobalamin group Chemical group 0.000 claims 1
- 235000019152 folic acid Nutrition 0.000 claims 1
- 239000011724 folic acid Substances 0.000 claims 1
- 235000003599 food sweetener Nutrition 0.000 claims 1
- 235000013922 glutamic acid Nutrition 0.000 claims 1
- 239000004220 glutamic acid Substances 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 239000011707 mineral Substances 0.000 claims 1
- 238000002156 mixing Methods 0.000 claims 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims 1
- 229960003512 nicotinic acid Drugs 0.000 claims 1
- 235000001968 nicotinic acid Nutrition 0.000 claims 1
- 239000011664 nicotinic acid Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 235000009566 rice Nutrition 0.000 claims 1
- 239000003765 sweetening agent Substances 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 229960003495 thiamine Drugs 0.000 claims 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
- 239000011782 vitamin Substances 0.000 claims 1
- 235000010374 vitamin B1 Nutrition 0.000 claims 1
- 239000011691 vitamin B1 Substances 0.000 claims 1
- 235000019163 vitamin B12 Nutrition 0.000 claims 1
- 239000011715 vitamin B12 Substances 0.000 claims 1
- 235000019158 vitamin B6 Nutrition 0.000 claims 1
- 239000011726 vitamin B6 Substances 0.000 claims 1
- 150000003697 vitamin B6 derivatives Chemical class 0.000 claims 1
- 235000019165 vitamin E Nutrition 0.000 claims 1
- 239000011709 vitamin E Substances 0.000 claims 1
- 150000003712 vitamin E derivatives Chemical class 0.000 claims 1
- 235000019168 vitamin K Nutrition 0.000 claims 1
- 239000011712 vitamin K Substances 0.000 claims 1
- 150000003721 vitamin K derivatives Chemical class 0.000 claims 1
- 229930003231 vitamins Natural products 0.000 claims 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 1
- 239000011701 zinc Substances 0.000 claims 1
- 229910052725 zinc Inorganic materials 0.000 claims 1
- 235000016804 zinc Nutrition 0.000 claims 1
Claims (5)
- オルニチン又はその塩と、下記（ａ）〜（ｄ）からなる群より選ばれる少なくとも１種の成分とを有効成分として含有することを特徴とする抗疲労剤。
（ａ）松、及び稲から選ばれる少なくとも１種の植物素材
（ｂ）アスパルテーム、トレハロース、及び還元パラチノースから選ばれる少なくとも１種の甘味剤
（ｃ）グルタミン、グルタミン酸、グリシン、ヒスチジン、イソロイシン、ロイシン、リジン、メチオニン、フェニルアラニン、チロシン、及びアンセリンから選ばれる少なくとも１種のアミノ酸類
（ｄ）ビタミンＢ６、ビタミンＢ１２、ビタミンＥ、ナイアシン、葉酸、ビタミンＫ、亜鉛、及びビタミンＢ１から選ばれる少なくとも１種のビタミン・ミネラル類 - オルニチン又はその塩と（ａ）〜（ｄ）からなる群より選ばれる少なくとも１種の成分とからなる有効成分を添加して得たことを特徴とする請求項１記載の抗疲労剤。
- オルニチン又はその塩と他の有効成分との配合質量比が、０．５：１〜７０：１の範囲であることを特徴とする請求項１又は２記載の抗疲労剤。
- 錠剤、カプセル剤、粉末剤、顆粒剤、又は液剤であることを特徴とする請求項１〜３のいずれか記載の抗疲労剤。
- 請求項１〜４のいずれか記載の抗疲労剤を摂取させることを特徴とする疲労軽減方法（ただし、医療行為を除く）。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015127862A JP6646369B2 (ja) | 2015-06-25 | 2015-06-25 | 抗疲労剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015127862A JP6646369B2 (ja) | 2015-06-25 | 2015-06-25 | 抗疲労剤 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019129279A Division JP6829487B2 (ja) | 2019-07-11 | 2019-07-11 | 抗疲労剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017008002A JP2017008002A (ja) | 2017-01-12 |
| JP2017008002A5 true JP2017008002A5 (ja) | 2019-03-14 |
| JP6646369B2 JP6646369B2 (ja) | 2020-02-14 |
Family
ID=57761280
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015127862A Active JP6646369B2 (ja) | 2015-06-25 | 2015-06-25 | 抗疲労剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6646369B2 (ja) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114847487A (zh) * | 2022-05-24 | 2022-08-05 | 李颖 | 甲萘醌-7在制备改善运动能力的产品中的应用及改善运动能力的产品 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004249023A1 (en) * | 2003-06-19 | 2004-12-29 | Suntory Limited | Movement physiology improver |
| JP2005097273A (ja) * | 2003-08-19 | 2005-04-14 | Toyo Shinyaku:Kk | 運動能力向上組成物 |
| US20100137226A1 (en) * | 2006-06-07 | 2010-06-03 | Kyowa Hakko Bio Co., Ltd | Fatigue-reducing agent |
| JP5687423B2 (ja) * | 2009-10-22 | 2015-03-18 | 協和発酵バイオ株式会社 | アルコール性疲労改善剤 |
| CN102430064B (zh) * | 2011-12-05 | 2013-07-24 | 张家港天乙传统医药研究院有限公司 | 一种用于补元气、通脉理血的组合物及其制备方法 |
-
2015
- 2015-06-25 JP JP2015127862A patent/JP6646369B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12016501310A1 (en) | Pharmaceutical compositions comprising azd9291 | |
| JP2016222689A5 (ja) | 合成ペプチド及び乾燥粉末薬剤輸送システム | |
| PH12019502033A1 (en) | Pharmaceutical composition comprising selexipag | |
| JP2017535616A5 (ja) | ||
| MX2016010179A (es) | Composiciones de donepezilo y métodos para tratar la enfermedad de alzheimer. | |
| JP2017507973A5 (ja) | ||
| WO2016142708A3 (en) | Pharmaceutical composition | |
| EA201791537A1 (ru) | Фармацевтическая композиция на основе наночастиц доцетаксела-альбумина, способ ее получения и ее применение | |
| WO2016140933A3 (en) | Immediate release soluble ibuprofen compositions | |
| WO2016191744A8 (en) | Oral composition of celecoxib for treatment of pain | |
| JP2012532891A5 (ja) | ||
| JP2017012144A5 (ja) | ||
| JP2017014155A5 (ja) | ||
| JP2017008002A5 (ja) | ||
| HRP20190676T1 (hr) | Pripravak za prevenciju ili liječenje sindroma policističnih jajnika i s njime povezanih simptoma | |
| JP2016210757A5 (ja) | ||
| JP2017008001A5 (ja) | ||
| EA201892842A1 (ru) | Фармацевтические композиции, включающие сафинамид | |
| JP2017002009A5 (ja) | ||
| ZA201905309B (en) | Pharmaceutical active ingredient and use thereof, in particular for the prevention and treatment of metabolic disorders in humans and animals | |
| JP2020509072A5 (ja) | ||
| MX2019005103A (es) | Composiciones de acido gamma-poliglutamico y zinc. | |
| JP2016216373A5 (ja) | ||
| JP2017007966A5 (ja) | ||
| JP2017014164A5 (ja) |